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Coronavirus Disease 2019 (COVID-19) caused by
the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was reported for the first time in
China in December 2019.[1] It has been spreading
rapidly worldwide and has emerged as the most
massive health crisis since World War II.[2, 3] The
World Health Organization (WHO) declared the
SARS-CoV-2 outbreak as a pandemic on March
12, 2019.[4] The COVID-19 pandemic is not only a
health crisis but also has a significant impact on
societies, economies, and progress rates toward
the United Nations’ sustainable development
goals.[5] The Eastern Mediterranean Region (EMR)
ranks third in the world in terms of the total
number of confirmed cases among the six WHO
regions.[6] Iran, as one of the EMR countries, has
reported 217,724 confirmed cases and 10,239
deaths from February 19 to June 26, 2020 (Figure
1).[2]
A recently published meta-analysis reported
that the risk of transmission is reduced by more
than 75% through implementing three strategies
by both healthcare workers and communities:
at least a 1-m social distancing, use of a face
masks (surgical or similar masks (12–16-layer
cotton or gauze masks), N95 respirators or
similar), and eye protection.[7] Recently, the
WHO has released interim guidance on the use
of masks for avoiding transmission of COVID-
19.[8]
Infected droplets can find their way into the
ocular surfaces where the virus can replicate.[9] An
overall pooled prevalence of ocular manifestations
in patients with COVID-19 was 5.5% in one
report.[10] There is limited published evidence
on the prevalence of ocular manifestations of
COVID-19 in Iran.[11] In a case series including 43
patients in Iran, reverse transcription-polymerase
chain reaction (RT-PCR) on nasopharyngeal
and tear samples indicated presence of viral
material in 30% and 7% of cases, respectively.
The nasopharyngeal RT-PCR results were
indicative of the presence of the virus in all
patients with positive tear RT-PCR results, which
comprised a case with clinical conjunctivitis.[11]
Although the rate of ocular manifestations is
low, protecting against viral transmission is vital
in ophthalmology practice due to the proximity
between the examiner and patients, the lengthy
period of exposure during examinations, and
direct contact with patient’s eye secretions.[12]
Many non-urgent ophthalmic services were
ceased at the ophthalmology centers in Iran,
similar to other countries, during the early months
of the pandemic to tackle the spread of COVID-
19.
Government agencies, ophthalmology societies,
and eye health centers have developed guidance
and policy statements to reduce the risk of
transmission on one hand and maintain continuity
of eye care on the other.[13–19] These blueprints
have included recommendations for modifying the
clinical pathway and disinfecting protocols, initial
screening, and necessary protective equipment
for eye care providers, including ophthalmologists,
optometrists, clinic/hospital managers, and staff.
Furthermore, triage for ophthalmic disorders and
cessation of elective examinations, diagnostic
procedures, and surgeries were addressed in
the guidance.[13–18] In response to the COVID-19
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Figure 1. Cumulative number of confirmed cases of COVID-19 and death from February 2020 to June 2020 in Iran.
pandemic in Iran, the Knowledge Management
Unit, Ophthalmic Research Center, Research
Institute for Ophthalmology and Vision Science,
Shahid Beheshti University of Medical Sciences,
in collaboration with the Iranian Society of
Ophthalmology published a joint guidance in
March 2020, which appears in this issue of
the journal.[20] The ad hoc committee urged
ophthalmologists to restrict non-emergent
services and provide care for conditions such
as retinal detachment, trauma, chemical burns,
dangerously elevated intraocular pressure,
and severe ocular infections. It recommended
postponing elective surgeries and counsel
patients using remote approaches. The use
of face masks, goggles, gloves, and slit-lamp
shields were emphasized for visiting urgent
cases. Infection control strategies, including
handwashing, disinfecting ophthalmic examination
equipment with 70% alcohol, and surfaces
with bleach-based disinfectants were also
recommended.[20]
After leaving behind the first peak of the
COVID-19 infection, ophthalmology centers were
reopened, and eye care services resumed
to prevent sight-threatening eye disorders
and to manage the backlog of postponed
appointments.[21] New guidance was developed for
the post-peak era, and existing recommendations
were updated. Naveed et al prepared guidance for
modifying the ophthalmic workplace for the post-
peak period.[22] The post-peak recommendation
addressed different strategies, including
engineering and administrative controls and
protecting workers with personal protective
equipment. The authors suggested tele-triage by
a senior physician for urgent cases, minimizing
face-to-face time in routine clinics, and limiting
general anesthesia to absolutely necessary
surgical cases.[22] The joint guidance was
also updated to provide recommendations
for protecting ophthalmic health workers and
ophthalmology centers during the post-peak era.
It now mandates physical distancing as well as
requirements for protecting ophthalmologists
and staff during surgeries. Cataract surgery
was considered as a semi-urgent operation that
could be performed in cases prone to falls and
subjects with significantly impaired vision.[20] Eye
Health and Prevention of Blindness Office of
the Center for Non-communicable Diseases
Control of the Ministry of Health and Medical
Education issued an official point of view in late
June. It offered detailed guidance for the public
and health workers, in addition to eye health
professionals during the COVID-19 pandemic. It
addresses ocular involvement by SARS-CoV-2 as
well.
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The WHO Regional Director for the EMR
notified a risk of an accelerated trend in the
number of confirmed cases in EMR countries
as a consequence of easing restrictions.[23]
Estimations by the Institute for Health Metrics
and Evaluation (IHME) also confirmed this
trend.[24] Therefore, to continue providing
care for ophthalmic patients, it is crucial that
ophthalmic care providers and staff follow the
guidance strictly to reduce the risk of infection
transmission from patients to medical care and
vice versa.
In summary, it seems that initial screening
at the time of admission, mandating social
distancing, washing hands, wearing face
masks by healthcare providers and patients,
use of slit lamp shields, and disinfecting the
instruments are reasonable protective strategies
recommended by various guidance. We have
to consciously monitor the pandemic status,
public health developments, and the evidence
which emerges to tailor and update our control
measures and eye care strategies. And we all
know that the COVID-19 pandemic, directly and
indirectly, has affected medical care and will
continue to transform it further in the coming
decade.
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